Simcere Pharmaceutical Group Limited Stock
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Hong Kong S.E.
06:08:04 14/09/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 11.39 HKD | +3.08% |
|
-1.64% | -4.85% |
| 04/09 | Simcere Pharma's Yingmule Gets China Marketing Approval for RSV Prevention | MT |
| 03/09 | Simcere Pharmaceutical Group Limited Announces Approval for Marketing of Yingmule in China | CI |
| Market Cap | 3.62B 28.38B 3.12B 2.95B 2.68B 5.02B 346B 5.05B 35.06B 13.48B 176B 13.59B 13.29B 556B | P/E 2026 * |
13.8x | P/E 2027 * | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 3.42B 26.83B 2.95B 2.79B 2.53B 4.75B 327B 4.77B 33.15B 12.75B 166B 12.85B 12.57B 525B | EV / Sales 2026 * |
2.28x | EV / Sales 2027 * | 2.06x |
| Free-Float |
32.13% | Yield 2026 * |
3.81% | Yield 2027 * | 4.33% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2096 | Delayed | |
OTC Markets
| SMHGF | Delayed | |
|
Tradegate
| S2P | Real-time | |
|
Deutsche Boerse AG
| S2P | Delayed | |
|
Börse Stuttgart
| S2P | Delayed | |
|
Boerse Muenchen
| S2P | Real-time |
| 1 day | +3.08% | ||
| 1 week | -1.64% | ||
| Current month | +2.61% | ||
| 1 month | -6.18% | ||
| 3 months | +12.66% | ||
| 6 months | -5.56% | ||
| Current year | -4.85% |
| 1 week | 10.92 |  | 11.76 |
| 1 month | 10.92 | | 12.82 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 14.38 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CEO | Chief Executive Officer | 63 | 20/08/2026 |
Yunshu Zhou
CEO | Chief Executive Officer | 54 | 25/03/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 19/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 08/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 19/11/2019 |
Renhong Tang
BRD | Director/Board Member | 46 | 01/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/8/26 | Other | Chairperson | -3,000,000 | 0.1168% | ||
| 13/7/26 | Other | Founder | -47,000 | 0.0018% | ||
| 13/7/26 | Other | Director | -47,000 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.08% | -1.64% | -17.22% | +76.32% | 3.62B | |
| -1.13% | -3.11% | +13.82% | +60.17% | 46.21B | |
| -0.62% | -3.96% | +32.92% | +106.77% | 38.78B | |
| +0.12% | -0.08% | +7.12% | +73.98% | 11.68B | |
| -0.53% | -1.37% | -13.25% | +11.19% | 11.55B | |
| -0.38% | -2.26% | +18.18% | +142.99% | 9.14B | |
| +0.48% | -0.94% | +24.16% | +36.26% | 7.3B | |
| +0.17% | -0.74% | +13.44% | +180.68% | 7.15B | |
| +0.75% | -3.35% | +34.11% | -19.22% | 7.1B | |
| -3.13% | -4.30% | -44.88% | +12.88% | 4.97B | |
| Average | -0.12% | -2.83% | +6.84% | +68.20% | 14.75B | |
| Weighted average by Cap. | -0.53% | -3.31% | +15.19% | +74.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.5B 11.78B 1.29B 1.23B 1.11B 2.08B 143B 2.09B 14.55B 5.59B 72.98B 5.64B 5.52B 231B | 1.69B 13.27B 1.46B 1.38B 1.25B 2.35B 162B 2.36B 16.4B 6.31B 82.26B 6.36B 6.22B 260B |
| Net income | 255M 2B 220M 208M 189M 354M 24.39B 356M 2.47B 951M 12.41B 959M 938M 39.22B | 302M 2.37B 260M 246M 223M 419M 28.83B 421M 2.92B 1.12B 14.67B 1.13B 1.11B 46.35B |
| Net Debt | -197M -1.55B -170M -161M -146M -274M -18.85B -275M -1.91B -735M -9.59B -741M -725M -30.3B | -140M -1.1B -120M -114M -103M -194M -13.35B -195M -1.35B -521M -6.79B -525M -513M -21.46B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/09/26 | HKD 11.39 | +3.08% | 7,211,232 |
| 11/09/26 | HKD 11.05 | -1.52% | 7,763,000 |
| 10/09/26 | HKD 11.22 | -3.03% | 5,096,000 |
| 09/09/26 | HKD 11.57 | -0.52% | 3,367,000 |
| 08/09/26 | HKD 11.63 | +0.43% | 2,111,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Select your edition
All financial news and data tailored to specific country editions
